Prompt

Are there any cell therapy research sites that focus on clinical and preclinical examples in gene editing and delivery?

Biotechnology / Therapeutics Biotech1 observationLast seen Jul 31, 2026

Latest observation

Jul 31, 2026OpenAI APIWeb search: off

Yes. There are several cell and gene therapy research sites and centers that focus specifically on clinical and preclinical work in gene editing and delivery. Depending on whether you mean academic research hubs, hospital-based translational programs, or industry-style cell therapy centers, good examples include:

Academic / Translational Centers

  • Stanford University (Snyder Lab / ChEM-H / stem cell programs)
    Strong in gene editing, CRISPR, and delivery technologies with both preclinical and translational work.

  • Broad Institute / Harvard / MIT-affiliated centers
    Major hub for CRISPR and genome editing; many groups work on delivery methods and therapeutic translation.

  • University of Pennsylvania – Center for Cellular Immunotherapies
    Highly active in clinical cell therapy and gene-modified cell therapy, especially CAR-T and related delivery/editing platforms.

  • UC Berkeley / UCSF / Gladstone-affiliated programs
    Strong preclinical research in delivery systems, genome editing, and therapeutic development.

  • Memorial Sloan Kettering Cancer Center
    Extensive clinical cell therapy research, including genetically engineered immune cells.

  • Dana-Farber / Boston Children’s / Harvard Medical School programs
    Active in both preclinical and clinical gene editing approaches, especially for blood disorders and cancer.

Specialized Gene Editing / Delivery Programs

  • Addgene-associated educational and research resources
    Not a clinical site itself, but useful for finding labs and vectors related to editing and delivery.

  • NIH intramural programs and NIH-funded consortia
    Multiple groups focused on delivery platforms, genome editing, and translational cell therapy.

  • Fred Hutchinson Cancer Center
    Strong in engineered immune cell therapies and translational gene-modification work.

  • Sangamo-associated academic/industry collaborations
    Known for gene editing development and delivery research.

If you want sites with both clinical and preclinical examples

These are often the best bets:

  1. University of Pennsylvania
  2. Broad Institute-affiliated groups
  3. Stanford
  4. Fred Hutch
  5. MSKCC
  6. UCSF / UC Berkeley translational programs

If you want, I can also give you:

  • a shortlist by disease area (cancer, sickle cell, neuro, ocular, etc.),
  • a list of specific labs or principal investigators,
  • or research site examples with active clinical trials in gene editing and delivery.

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.